Next Article in Journal
Mapping of Human Polyomavirus in Renal Cell Carcinoma Tissues
Previous Article in Journal
Analysis of HLA Alleles in Different Cohorts of Patients Infected by L. infantum from Southern Spain
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
This is an early access version, the complete PDF, HTML, and XML versions will be available soon.
Review

Ferroptosis in Arthritis: Driver of the Disease or Therapeutic Option?

1
Faculty of Medicine, University of Bern, 3012 Bern, Switzerland
2
Department of Rheumatology and Immunology, Bern University Hospital, University of Bern, 3010 Bern, Switzerland
3
Department for BioMedical Research DBMR, University of Bern, 3008 Bern, Switzerland
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2024, 25(15), 8212; https://doi.org/10.3390/ijms25158212 (registering DOI)
Submission received: 30 April 2024 / Revised: 12 July 2024 / Accepted: 22 July 2024 / Published: 27 July 2024
(This article belongs to the Special Issue Regulation of Inflammatory Reactions in Health and Disease 3.0)

Abstract

Ferroptosis is a form of iron-dependent regulated cell death caused by the accumulation of lipid peroxides. In this review, we summarize research on the impact of ferroptosis on disease models and isolated cells in various types of arthritis. While most studies have focused on rheumatoid arthritis (RA) and osteoarthritis (OA), there is limited research on spondylarthritis and crystal arthropathies. The effects of inducing or inhibiting ferroptosis on the disease strongly depend on the studied cell type. In the search for new therapeutic targets, inhibiting ferroptosis in chondrocytes might have promising effects for any type of arthritis. On the other hand, ferroptosis induction may also lead to a desired decrease of synovial fibroblasts in RA. Thus, ferroptosis research must consider the cell-type-specific effects on arthritis. Further investigation is needed to clarify these complexities.
Keywords: ferroptosis; ROS; lipid peroxidation; iron; rheumatoid arthritis; osteoarthritis; RA-FLS; chondrocytes ferroptosis; ROS; lipid peroxidation; iron; rheumatoid arthritis; osteoarthritis; RA-FLS; chondrocytes

Share and Cite

MDPI and ACS Style

Bieri, S.; Möller, B.; Amsler, J. Ferroptosis in Arthritis: Driver of the Disease or Therapeutic Option? Int. J. Mol. Sci. 2024, 25, 8212. https://doi.org/10.3390/ijms25158212

AMA Style

Bieri S, Möller B, Amsler J. Ferroptosis in Arthritis: Driver of the Disease or Therapeutic Option? International Journal of Molecular Sciences. 2024; 25(15):8212. https://doi.org/10.3390/ijms25158212

Chicago/Turabian Style

Bieri, Shania, Burkhard Möller, and Jennifer Amsler. 2024. "Ferroptosis in Arthritis: Driver of the Disease or Therapeutic Option?" International Journal of Molecular Sciences 25, no. 15: 8212. https://doi.org/10.3390/ijms25158212

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop